BROADWOOD CAPITAL INC
Follow13F filer, CIK 1278387, New York, NY
BROADWOOD CAPITAL INC reported $1,913,155,086 across 6 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000919574-26-005163
- Period
- 2026-06-30
- Reported value
- $1.91B
- Holdings
- 6
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| IMDXadded | +753,045 | $4.44M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
None.
Holdings, Q2 2026
Share positions as resolved from 13F-HR 0000919574-26-005163, largest first. % of portfolio is the value over $1,913,155,086, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| MNSTMONSTER BEVERAGE CORP NEW | 8,107,796 | $779M | 40.73% | 0 | Timeline | ||
| STAASTAAR SURGICAL CO | 16,123,842 | $463M | 24.18% | 0 | Timeline | ||
| AXONAXON ENTERPRISE INC | 693,504 | $389M | 20.32% | 0 | Timeline | ||
| IWMISHARES TR | 474,920 | $143M | 7.46% | 0 | Timeline | ||
| IMDXINSIGHT MOLECULAR DIA INC | 12,684,884 | $74.8M | 3.91% | +753,045 | Timeline | ||
| LCTXLINEAGE CELL THERAPEUTICS IN | 49,560,992 | $64.9M | 3.39% | 0 | Timeline |
How Q2 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000919574-26-005163 | base | 2026-08-14 | acceptance time not in the bulk data set |